Pharma BD Deal Intelligence
Danaher Corporation / Abcam PLC
2023 · Acquisition/Merger · $5.7B · Complete
Announcement Sentiment
70
Positive
Outcome Score
77
Worked — the deal delivered on its rationale.
Danaher acquired Abcam for $5.7B for antibodies, reagents, and proteomic research tools.
Key facts
- Announced Aug 28, 2023
- Closed Dec 06, 2023
- Deal value $5.7B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals